Skip to main content
. 2017 Jan 24;2017(1):CD009090. doi: 10.1002/14651858.CD009090.pub2

Summary of findings for the main comparison. Metformin versus placebo co‐treatment for assisted reproduction for subfertility associated with polycystic ovary syndrome.

Metformin versus placebo co‐treatment for assisted reproduction for subfertility associated with polycystic ovary syndrome
Patient or population: patients with subfertility associated with polycystic ovary syndrome
 Settings: outpatient
 Intervention: metformin vs placebo co‐treatment for assisted reproduction
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) Number of participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
Placebo co‐treatment Metformin co‐treatment
Live birth rate (per woman) 
 Follow‐up: 3‐6 months 267 per 1000 457 per 1000
190 more per 1000 (42 to 345)
OR 2.31 
 (1.24 to 4.33) 180
 (2 studies) ⊕⊕⊝⊝
 Lowa  
Multiple pregnancy rate (per woman) 52 per 1000 26 per 1000
23 fewer per 1000 (44 fewer to 25 more)
OR 0.55
(0.15 to 1.95)
232
 (4 studies) ⊕⊕⊝⊝
 Lowa,b  
Ongoing pregnancy rate (per woman) 217 per 1000 393 per 1000
189 more per 1000 (57 to 336)
OR 2.46 
 (1.36 to 4.46) 232
 (4 studies) ⊕⊕⊝⊝
 Lowa  
Clinical pregnancy rate (per woman) 252 per 1000 444 per 1000
206 more per 1000 (78 to 340)
OR 2.51 
 (1.46 to 4.31) 264
 (5 studies) ⊕⊕⊝⊝
 Lowa  
*The basis for the assumed risk (e.g. median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: confidence interval; OR: odds ratio.
GRADE Working Group grades of evidence.
 High quality: Further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: We are very uncertain about the estimate.

aLimited sample size, limited precision, lack of blinding of participants and of outcome assessors.
 bMultiple pregnancy had a very low incidence.